FDA Adverse Event Injury Summary report: N

LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM

MDR report key: 1230516 · Received November 12, 2008

Report

Report Number
2024601-2008-00854
Event Type
Injury
Date Received
November 12, 2008
Date of Event
September 15, 2004
Report Date
October 14, 2008
Manufacturer
COSTA RICA
Product Code
LTI
PMA / PMN Number
P000008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

TAPER II. THE REPORTER OF THE COMPLAINT WAS ASKED TO RETURN THE PRODUCT FOR ANALYSIS, AS WELL AS INDICATE THE PRODUCT SERIAL NUMBER, DATE OF EVENT, IMPLANT DATE AND EXPLANT DATE. THE INFORMATION HAS NOT BEEN RECEIVED BY ALLERGAN. BASED ON THE PROBABLE IMPLANT DATE, THE TAPER TYPE IS ASSUMED TO BE A TAPER II. VISUAL EXAMINATION MAY DETERMINE THE CONNECTOR TYPE ASSOCIATED WITH THIS REPORT. ALLERGAN HAS NOT RECEIVED THE PRODUCT AT THIS TIME. THEREFORE, NO ANALYSIS OR TESTING HAS BEEN DONE. MULTIPLE REQUESTS FOR FURTHER INFORMATION HAVE BEEN MADE ALLERGAN HAS RECEIVED NO RESPONSE FROM THE AUTHORS. VOMIT IS A SURGICAL/PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. DEVICE LABELING: "NAUSEA AND VOMITING MAY OCCUR, PARTICULARLY IN THE FIRST FEW DAYS AFTER SURGERY AND WHEN THE PATIENT EATS MORE THAN RECOMMENDED."

Description of Event or Problem · 1

REPORTED EVENT OF READMISSION TO THE HOSPITAL, DUE TO VOMITING FROM JOURNAL ARTICLE "ONE-YEAR READMISSION RATES AT A SURGERY CENTER: LAPAROSCOPIC ADJUSTABLE GASTRIC BANDING, LAPAROSCOPIC GASTRIC BYPASS, AND VERTICAL BANDED GASTROPLASTY-ROUX-EN-Y GASTRIC BYPASS", J. SAUNDERS, ET AL (2008) OBES SURG 18:1233-1240 SPRINGER SCIENCE. ALLERGAN'S APPROACH TO COMPLIANCE IS TO RESOLVE ALL DOUBT IN FAVOR OF REPORTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM DEVICE FOR TREATMENT OF MORBID OBESITY LTI COSTA RICA N/A NI

Patients

Seq Age Sex Outcome Treatment
1 NI Hospitalization| R